These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 22905176)

  • 1. Growth factor-activated stem cell circuits and stromal signals cooperatively accelerate non-integrated iPSC reprogramming of human myeloid progenitors.
    Park TS; Huo JS; Peters A; Talbot CC; Verma K; Zimmerlin L; Kaplan IM; Zambidis ET
    PLoS One; 2012; 7(8):e42838. PubMed ID: 22905176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
    Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
    PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.
    Chicha L; Feki A; Boni A; Irion O; Hovatta O; Jaconi M
    PLoS One; 2011 Feb; 6(2):e14733. PubMed ID: 21364915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.
    Park TS; Zimmerlin L; Zambidis ET
    Cytometry A; 2013 Jan; 83(1):114-26. PubMed ID: 22736485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
    Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
    Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficient reprogramming of human cord blood CD34(+) cells for formation of induced pluripotent stem cells with non-integrating plasmid system].
    Zhang QE; Liu SP; Liu YF; Zhang HY; Yuan WP; Chen GB; Li YX; Xu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):728-34. PubMed ID: 23815931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
    Verfaillie CM; Miller JS
    Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
    Ebrahimi B
    Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
    Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
    Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient generation, purification, and expansion of CD34(+) hematopoietic progenitor cells from nonhuman primate-induced pluripotent stem cells.
    Gori JL; Chandrasekaran D; Kowalski JP; Adair JE; Beard BC; D'Souza SL; Kiem HP
    Blood; 2012 Sep; 120(13):e35-44. PubMed ID: 22898598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
    Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
    Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines.
    Woods NB; Parker AS; Moraghebi R; Lutz MK; Firth AL; Brennand KJ; Berggren WT; Raya A; Izpisúa Belmonte JC; Gage FH; Verma IM
    Stem Cells; 2011 Jul; 29(7):1158-64. PubMed ID: 21544903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of mouse and human induced pluripotent stem cells (iPSC) from primary somatic cells.
    Lorenzo IM; Fleischer A; Bachiller D
    Stem Cell Rev Rep; 2013 Aug; 9(4):435-50. PubMed ID: 23104133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OP9 stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cells.
    Ji J; Vijayaragavan K; Bosse M; Menendez P; Weisel K; Bhatia M
    Stem Cells; 2008 Oct; 26(10):2485-95. PubMed ID: 18669904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balance of positive and negative effects of TGF-β signaling regulates the development of hematopoietic and endothelial progenitors in human pluripotent stem cells.
    Bai H; Xie YL; Gao YX; Cheng T; Wang ZZ
    Stem Cells Dev; 2013 Oct; 22(20):2765-76. PubMed ID: 23758278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
    Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
    Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.
    Siena S; Bregni M; Brando B; Belli N; Ravagnani F; Gandola L; Stern AC; Lansdorp PM; Bonadonna G; Gianni AM
    Blood; 1991 Jan; 77(2):400-9. PubMed ID: 1702334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.